Literature DB >> 1625145

Ovarian teratoma with gliomatosis peritonei.

J H Chaung1, L Chen.   

Abstract

Gliomatosis peritonei (GP) is a rare occurrence associated exclusively with ovarian teratoma (OT), in which numerous metastatic nodules composed mainly of mature glial tissue are studded on the peritoneum, omentum, and bowel wall. Two female patients (aged 5 years and 14 years) are reported. Various preoperative examinations confirmed a large abdominal teratoma with normal alpha-fetoprotein and beta-HCG. The OT was excised and partial omentectomy and incidental appendectomy were performed to remove as many metastatic nodules as possible. Pathological examinations including immunostains for glial fibrillary acidic protein showed predominantly mature glial tissue in the OT and in the metastatic nodules. An addition, chemotherapy was given to one of them, but both were well without recurrent diseases 17 months and 12 months postoperatively, respectively. The outcome of these two cases, in contrast to advanced malignancy in widespread intraperitoneal metastases of any other kind, supports the concept of benign nature of GP and a conservative surgical approach to this rare disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1625145     DOI: 10.1016/0022-3468(92)90474-l

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma.

Authors:  Na Ra Yoon; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae; Insuk Sohn; Chang Ohk Sung; Sang Yong Song
Journal:  Virchows Arch       Date:  2012-07-21       Impact factor: 4.064

2.  One man, one disease?

Authors:  Frankie Wai Tsoi Cheng; K F To; V Lee; M M K Shing; W K Leung; C K Li
Journal:  BMJ Case Rep       Date:  2009-04-28

3.  Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases.

Authors:  Li Liang; Yifen Zhang; Anais Malpica; Preetha Ramalingam; Elizabeth D Euscher; Gregory N Fuller; Jinsong Liu
Journal:  Mod Pathol       Date:  2015-11-13       Impact factor: 7.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.